Compare BOF & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOF | IINN |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 35.3M |
| IPO Year | 2023 | N/A |
| Metric | BOF | IINN |
|---|---|---|
| Price | $4.05 | $0.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 101.5K | ★ 193.4K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,184,018.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9,715.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 258.20 | N/A |
| 52 Week Low | $1.53 | $0.40 |
| 52 Week High | $4.95 | $1.65 |
| Indicator | BOF | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 54.27 | 32.51 |
| Support Level | $2.85 | $0.55 |
| Resistance Level | $4.95 | $1.12 |
| Average True Range (ATR) | 0.36 | 0.03 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 33.76 | 16.98 |
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.